Ockham

Harman Dubé has been appointed vice president of the Preclinical and Regulatory Affairs group within OckhamCRO. Dr. Dubé has 14 years of experience in developing and directing a variety of drug and device development programs, supporting pharma and biopharma organizations with development efforts. Her areas of experience include consultation on, and management of, non-clinical studies, CMC activities and U.S. and International regulatory filings, technical writing and project management.

Prior to joining the company, Dr. Dubé headed the drug development program at Thrasos Innovation in Canada, managing all aspects of planning and execution of non-clinical studies, regulatory filings and Phase I study operations. Dr. Dubé also led the drug development efforts for PainCeptor Pharma (Canada), managing the clinical, regulatory, and CMC activities for two pain programs. Prior to that, she spent 10 years at Abbott Laboratories in the U.S., where she held positions of increasing management responsibility in the areas of project management, pre-clinical, applied research, and strategic marketing programs.

Ockham’s chief executive officer, James Baker, said, “We are pleased to have such an experienced leader enhance Ockham’s service offerings in Product Development and Regulatory. We see a tremendous need for this service as we try and work with our sponsors to get needed products to market faster, in order to enhance our quality of life.”